MedTrace Logo

Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy

NCT01053559 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2014-04-24

No results posted yet for this study

Summary

Wireless Capsule Endoscopy has been the most reliable diagnostic standard for small bowel Crohn's disease. Endoscopic healing is an important endpoint to measure response to treatment.

Conditions

Interventions

DRUG

certolizumab pegol

400mg subcutaneous injections at week 0, week 2, week 4, then every 4 weeks thereafter

Sponsors & Collaborators

  • UCB Pharma

    collaborator INDUSTRY

  • Shafran Gastroenterology Center

    lead OTHER

Principal Investigators

  • Ira Shafran, M.D. · Shafran Gastroenterology Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01053559 on ClinicalTrials.gov